5AM Ventures V reports Entrada Therapeutics share disposal worth $431,620
TRDA•5AM Ventures V reduces Entrada Therapeutics stake
5AM Ventures V sold 62,811 Entrada Therapeutics common shares on Aug. 6–7 at weighted-average prices of $7 and $6.85.
Direct stake fell to 2,783,781 shares following the sales.
5AM Opportunities I held 1,093,313 shares indirectly as of the filing.
